CERT Certara, Inc.

10.68USD-4.47%Mkt Cap: 1.63B USDP/E: —

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access i…

Institutional holders20 on file

Key Statistics

Company
Market Cap1.63B USD
Enterprise Value1.79B USD
Revenue (TTM)425.76M USD
Gross Profit257.71M USD
Net Income (TTM)-1.59M USD
Revenue/Share2.73 USD
Last Price10.68 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)27.30
PEG—
EV/EBITDA17.64
EV/Revenue4.20
P/S3.83
P/B1.67
EPS (TTM)-0.18 USD
EPS (Forward)0.39 USD
52W Range
4.45076% of range12.61
52W High12.61 USD
52W Low4.450 USD
Profitability
Gross Margin61.53%
Oper. Margin5.75%
EBITDA Margin23.84%
Profit Margin-0.38%
ROE-0.15%
ROA-0.10%
ROIC0.89%
ROCE1.50%
Growth
Revenue Growth4.40%
Earnings Growth285.20%
Cash Flow & Leverage
Operating CF96.33M USD
CapEx (TTM)26.56M USD
FCF Margin15.52%
FCF Yield4.06%
Net Debt84.43M USD
Net Debt/EBITDA0.83
Net Debt/FCF1.28
Balance Sheet
Debt/Equity0.29
Current Ratio2.58
Quick Ratio2.48
Book Value/Sh6.41 USD
Cash/Share1.42 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.68 USD
Upside (mean)+18.7%
Target Range10.00 USD – 15.00 USD
10.00+18.7% to mean15.00
# Analysts11
Ownership
Shares Out.152.54M
Float111.96M
Insiders2.73%
Institutions112.55%
Short Interest
Short Ratio9.5d
Short % Float26.21%
Short % Out.16.74%
Shares Short25.53M
Short (prev mo.)27.70M
Technical
SMA 509.768 (+9.3%)
SMA 2007.379 (+44.7%)
Beta1.25
S&P 52W Chg12.08%
Avg Vol (30d)2.60M
Avg Vol (10d)3.34M
Technical Indicators
RSI (14)47.4
MACD0.3745
MACD Signal0.5531
MACD Hist.-0.1786
BB Upper12.46 USD
BB Middle11.32 USD
BB Lower10.18 USD
BB Width20.15%
ATR (14)0.5835 USD
Vol Ratio (20d)0.66x

About Certara (NASDAQ: CERT)

›

Certara (NASDAQ: CERT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 1,515 employees.

The shares were at 10.68 USD on 19 November 2026, down 5.2% over 52 weeks. Its 52-week range is 4.450 USD to 12.61 USD: the price is 15.3% below the high and 140.0% above the low.

Its market capitalisation is 1.63B USD.

Certara reports return on equity of -0.2%, an operating margin of 5.8% and revenue up 4.4% year over year.

Its debt exceeds its cash by 84.43M USD, a debt-to-equity ratio of 0.29. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 11 analysts cover the stock, with an average rating of Buy; their mean price target of 12.68 USD is 18.7% above the current price. The next earnings report is expected on 25 February 2027.